— Know what they know.
Not Investment Advice

DIVISLAB.BO

Divi's Laboratories Limited
1W: -0.3% 1M: -3.6% 3M: -7.0% YTD: -1.8% 1Y: -0.0% 3Y: +84.5% 5Y: +67.8%
₹6,012.95 ($64.01)
-9.95 (-0.17%)
 
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ₹1.60T · Alpha Radar Strong Sell · Power 34
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap₹1.60T ($17.0B)
52W Range4941.7-7077.7
Volume5,025
Avg Volume16,756
Beta0.12
Dividend₹30.00
Analyst Ratings
No analyst coverage
Company Info
CEOKiran Satchandra Divi
Employees9,741
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2003-03-25
Divi Towers
Hyderabad 500032
IN
91 40 6696 6300
About Divi's Laboratories Limited

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, North America, Asia, Europe, and internationally. It also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms